| 紀錄類型: |
書目-語言資料,印刷品
: Monograph/item
|
| 正題名/作者: |
Cancer imaging/ edited by M.A. Hayat. |
| 其他作者: |
Hayat, M. A., |
| 出版者: |
Amsterdam ;Elsevier, Academic Press, : c2008-, |
| 面頁冊數: |
v. :ill. (some col.) ;29 cm. |
| 叢書名: |
Cancer imaging |
| 內容註: |
V. 1: Strategies for imaging biology in cancer and other diseases -- Synthesis of p18 sF-fluoromisonidazole tracer for positron emission tomography -- Radiation hormesis -- Molecular imaging in early therapy monitoring -- Positron emission tomography in medicine: an overview -- Radiation dose and image quality -- Contrast agents for magnetic resonance imaging: an overview -- Whole-body computed tomography screening -- Whole-body p18 sF-fluorodeoxyglucose-positron emission tomography: is it valuable for health screening? -- Staging solid tumors with p18 sF-fluorodexoyglucose-positron emission tomography/computed tomography -- Laser doppler perfusion imaging: clinical diagnosis -- Dynamic sonographic tissue perfusion measurement with the pixelflux method -- Immuno-positron emission tomography -- Role of imaging biomarkers in drug development -- The role of imaging in lung cancer -- Lung cancer staging: integrated p18 sF-fluorodeoxyglucose-positron emission tomography/computed tomography and computed tomography alone -- Computed tomography screening for lung cancer -- Lung cancer: role of multislice computed tomography -- Surgically resected pleomorphic lung carcinoma: computed tomography -- Lung cancer: low dose helical computed tomography -- Lung cancer: computer-aided diagnosis with computed tomography -- Stereotactic radiotherapy for non-small lung carcinoma computed tomography -- Thin-section computed tomography correlates with clinical outcome in patients with mucin-producing adenocarcinoma of the lung -- Non-small lung carcinoma: p18 sF-fluorodeoxyglucose-positron emission tomography -- Evaluating positron emission tomography in non-small cell lung cancer: moving beyond accuracy to outcome -- Non-small cell lung cancer: false-positive results with p18 sF-fluorodeoxyglucose-positron emission tomography -- Oxygen-enhanced proton magnetic resonance imaging of the human lung -- Detection of pulmonary gene transfer using iodide-124/positron emisson tomography -- Lung cancer with idiopathic pulmonary fibrosis: high-resolution computed tomography -- Categorization of mammographic density for breast cancer: clinical significance -- Breast tumor classification and visualization with machine-learning approaches -- Mass detection scheme for digitized mammography -- Full-field digital phase-contrast mammography -- Full-field digital mammography versus film-screen mammography -- Use of contrast-enhanced magnetic resonance imaging for detecting invasive lobular carcinoma -- |
| 內容註: |
Axillary lymph node status in breast cancer: pinhole collimator single-photon emission computed tomography -- Detection of small-size primary breast cancer: p99 smTc-tetrofosmin single photon emission computed tomography -- Microcalcification in breast lesion: radiography and histopathology -- Benign and malignant breast lesions: doppler sonograpy -- Response to neoadjuvant treatment in patients with locally advanced brest cancer: color-doppler ultrasound contrast medium (levovist) -- Magnetic resonance spectroscopy of breast cancer: current techniques and clinical applications -- Breast scintigraphy -- Primary breast cancer: false-negative and false-positive bone scintigraphy -- Improved sensitivity and specificity of breast cancer thermography -- Optical mammography -- Digital mammography -- Screening for breast cancer in women with a familial or genetic predisposition: magnetic resonance imaging versus mammography -- Mammographic screening: impact on survival -- False-positive mammography examinations -- Breast dose in thoracic computed tomography -- Absorbed dose measurement in mammography -- Metastatic choriocarcinoma to the breast: mammography and color doppler ultrasound -- Detection and characterization of breast lesions: color-coded signal intensity curve software for magnetic resonance-based breast imaging -- Detection of breast malignancy: different magnetic resonance imaging modalities -- Breast lesions: computerized analysis of magnetic resonance imaging -- Optical imaging techniques for breast cancer -- Magnetic resonance imaging: measurements of breast tumor volume and vascularity for monitoring response to treatment -- Defining advanced breast cancer: p18 sF-fluorodeoxyglucose-positron emission tomography -- Leiomyoma of the breast parenchyma: mammographic, sonographic, and histopathologic features -- Detection of breast cancer: dynamic infrared imaging -- Phyllodes breast tumors: magnetic resonance imaging. |
| 內容註: |
V. 2: Proton computed tomography -- Multidetector computed tomography -- Megavoltage computed tomography imaging -- Integrated set-3000G/X positron emission tomography scanner -- High-resolution magic angle spinning magnetic resonance spectroscopy -- Spatial dependency of noise and its correlation among various imaging modalities -- Computed tomography scan methods account for respiratory motion in lung cancer -- Respiratory motion artifact using positron emission tomography/computed tomography -- Gadolinium-based contrast media used in magnetic resonance imaging: an overview -- Molecular imaging of cancer with superparamagnetic iron-oxide nanoparticles -- Adverse reactions to iodinated contrast media -- The accuracy of diagnostic radiology -- Diffraction-enhanced imaging: applications to medicine -- Role of imaging in drug development -- Characterization of multiple aspects of tumor physiology by multitracer positron emission tomography -- Whole-body magnetic resonance imaging in patients with metastases -- Whole-body imaging in oncology: positron emission tomography/computed tomography (PET/CT) -- Whole-body cancer imaging: simple image fusion with positron emission tomography/computed tomography -- Whole body tumor imaging: O-[ p11 sC]methyl-L-tyrosine/positron emission tomography -- Tumor proliferation 2-[ p11 sC]-thymidine positron emission tomography -- p18 sF-fluorodeoxyglucose-positron emission tomography in oncology: advantages and limitations -- Positron emission tomography imaging of tumor hypoxia and angiogenesis: imaging biology and guiding therapy -- Noninvasive determination of angiogenesis: molecular targets and tracer development -- Gross tumor volume and clinical target volume: anatomical computed tomography and functional FDG-PET -- Post-treatment changes in tumor microenvironment: dynamic contrast-enhanced and diffusion-weighted magnetic resonance imaging -- In vivo molecular imaging in oncology: principles of reporter gene expression imaging -- Medical radiation-induced cancer -- Adrenal lesions: role of computed tomography, magnetic resonance imaging, p18 sF-fluorodeoxyglucose-positron emission tomography, and positron emission tomography/computed tomography -- Hemangioendothelioma: whole-body technetium-99m red blood cell imaging-magnetic resonance imaging -- Malignant bone involvement: assessment using positron emission tomography/computed tomography -- Bone metastasis: single photon emission computed tomography/computed tomography -- Bone cancer: comparison of p18 sF-fluorodeoxyglucose-positron emission tomography with single photon emission computed tomography -- Bone metastasis in endemic nasopharyngeal carcinoma: p18 sF-fluorodeoxyglucose-positron emission tomography -- Colorectal polyps: magnetic resonance colonography -- Early bile duct carcinoma: ultrasound, computed tomography, cholangiography, and magnetic resonance cholangiography -- Incidental extracolonic lesions: computed tomography -- Colorectal cancer: magnetic resonance imaging-cellular and molecular imaging -- |
| 內容註: |
Potential new staging perspectives in colorectal cancer: whole-body PET/CT-colonography -- Thoracic esophageal cancer: interstitial magnetic lymphography using superparamagnetic iron -- Esophageal cancer; comparsion of p18 sF-fluoro-3deoxy-3-[L]-fluorothymidine-positron emission tomography with p18 sf-fluorodeoxyglucose-positron emission tomography -- Gastrointestinal stromal tumors: positron emission tomography and contrast-enhanced helical computed tomography -- Gastrointestinal stromal tumor: computed tomography -- Gastrointestinal lipomas: computed tomography -- Computed tomography in peritoneal surface malignancy -- Gastrointestinal tumors: computed tomography/endoscopic ultrasonography -- Magnetic resonance cholangiopancreatography -- Occult primary head and neck carcinoma: role of positron emission tomography imaging -- Benign and malignant nodes in the neck: magnetic resonance microimaging -- Oral squamous cell carcinoma: comparison of computed tomography with magnetic resonance imaging -- Computed tomography in renal cell carcinoma -- Renal cell carcinoma subtypes: multislice computed tomography -- Renal impairment: comparison of noncontrast computed tomography, magnetic resonance urography, and combined abdominal radiography/ultrasonography -- Renal lesions: magnetic resonance diffusion-weighted imaging -- Malignant lymphoma: p18 sF-fluorodeoxyglucose-positron emission tomography -- Malignant melanoma: positron emission tomography -- Multiple myeloma: scintigraphy using technetium-99m-2-methoxyisobutylisonitrile -- Nasopharyngeal carcinoma: p18 sF-fluorodexyglucose-positron emission tomography -- Nasopharyngeal carcinoma for staging and restaging with p18 sF-FDG-PET/CT -- Ovarian sex cord stromal tumors: computed tomography and magnetic resonance imaging -- Malignant germ cell tumors: computed tomography and magnetic resonance imaging -- Ovarian small round cell tumors: magnetic resonance imaging -- Ovarian borderline serous surface papillary tumor: magnetic resonance imaging -- Chronic pancreatics versus pancreatic cancer: positron emission tomography -- Pancreatic cancer: P-[ p123 sl] lodo-L-phenylalanine single photon emission tomography for tumor imaging -- Pancreatic islet cell tumors: endoscopic ultrasonography -- Parotid gland tumors: advanced imaging technologies -- Pituitary macroadenomas: intraoperative magnetic resonance imaging and endonasal endoscopy -- Penile cancer staging: p18 sF-fluorodeoxyglucose-positron emission tomography/computed tomography -- Malignant peripheral nerve sheath tumors: [ p18 sF]fluorodeoxyglucose-positron emission tomography -- Prostate cancer: p11 sC-choline-positron emission tomography -- Metabolic characterization of prostate cancer: magnetic resonance spectroscopy -- Prostate cancer: diffusion-weighted imaging -- Prostatic secretory protein of 94 amino acids, gene-directed transgenic prostate cancer: three-dimensional ultrasound microimaging -- Prostate cancer within the transition zone: gadolinium-enhanced magnetic resonance imaging -- Rectal wall invasion of locally advanced prostate cancer: comparison of magnetic resonance imaging with transrectal ultrasound -- Local staging of prostate cancer using endorectal coil magnetic resonance imaging -- Extremity sarcoma: positron emission tomography -- Retroperitoneal synovial sarcoma: color-doppler ultrasound, computed tomography, and magnetic resonance imaging -- Thymona: computed tomography -- Hemolymphangiomatosis of the spleen: conventional diagnostic imaging and magnetic resonance imaging with superparamagnetic contrast agent -- Thyroid cancer: p18 sF-FDG-positron emission tomography -- Thyroid cancer: p18 sF-fluoro-2-deoxy-D-glucose-positron emission tomography (an overview) -- Diagnosis of thyroid cancer in children: value of power doppler ultrasound. |
| 標題: |
Cancer - Imaging. - |
| 電子資源: |
http://www.sciencedirect.com/science/book/9780123742124An electronic book accessible through the World Wide Web; click for information |
| 電子資源: |
http://www.loc.gov/catdir/toc/ecip079/2007002969.html |
| ISBN: |
0123742129 |